Physician profile
Stephen D Webber
NPI 1942295167
$12,861.93
in general payments reported to CMS, 2019-2025
11 companies · $86.06 in 2025
The $86.06 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,489 · 2020: $1,290 · 2021: $1,223 · 2022: $1,639 · 2023: $1,801 · 2024: $2,333 · 2025: $86.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,660 · Food and Beverage: $1,560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,659.54 |
| Food and Beverage | $1,560.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supreme Orthopedic Systems, LLC | $7,787.49 | 2019-2024 | |
| Arthrex, INC. | $4,401.42 | 2019-2024 | |
| Zimmer Biomet Holdings, INC. | $194.49 | 2024 | |
| Stryker Corporation | $165.88 | 2019-2020 | |
| Camber Spine Technologies LLC | $127.57 | 2020 | |
| Native Surgical, LLC | $60.33 | 2025 | |
| Depuy Synthes Sales INC. | $32.94 | 2019-2024 | Orthovisc |
| Acelrx Pharmaceuticals, INC. | $26.31 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $25.73 | 2025 | Exparel, Zilretta |
| Endo Pharmaceuticals INC. | $23.47 | 2021 | |
| Orthofix Medical, INC. | $16.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Webber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.